Skip to search formSkip to main contentSkip to account menu

clopidogrel

Known as: Clopidogrelum, clopidogrel [Chemical/Ingredient], methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate 
a kind of anti-clotting drug
National Institutes of Health

Related topics

Related topics

21 relations
Blood Coagulation DisordersCerebral InfarctionCoronary ThrombosisDrug Allergy

Narrower (6)

Clopidogrel bisulfateIscoverPlavixSR 25989

Broader (4)

Platelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsThiopheneTiclopidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel.
Review
2012
Review
2012
Clopidogrel: A Case for Indication‐Specific Pharmacogenetics
The CYP2C19*2 loss‐of‐function allele is associated with reduced generation of active metabolites of clopidogrel. However, meta… 
Highly Cited
2011
Highly Cited
2011
Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
Background— Recently published data indicate that the paraoxonase-1 (PON1) Q192R genotype—and not as previously shown activity of… 
2010
2010
Impacto del tipo de hospital en el tratamiento y evolución de los pacientes con síndrome coronario agudo sin elevación del ST
Review
2008
Review
2008
Clopidogrel‐Associated Bleeding and Related Complications in Patients Undergoing Coronary Artery Bypass Grafting
Objective. To determine if clopidogrel use before coronary artery bypass grafting (CABG) is associated with an increase in major… 
Review
2006
Review
2006
Aspirin and clopidogrel resistance: consideration and management.
The efficacy with aspirin and clopidogrel treatment has been demonstrated in various clinical trials. Laboratory evaluation of… 
Highly Cited
2006
Highly Cited
2006
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy
The efficacy of the platelet P2Y12 receptor antagonist clopidogrel, which undergoes cytochrome-mediated metabolism to its active… 
Review
2005
Review
2005
The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Highly Cited
2002
Highly Cited
2002
Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency.
Review
2001
Review
2001
Pharmacologic preservation of the hemostatic system during cardiac surgery.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)